Norton Rose Fulbright has hired a senior competition partner from Covington & Burling for its Brussels antitrust team. The appointment of Miranda Cole will bolster the breadth and depth of the firm’s global antitrust and competition team.
Miranda Cole brings with her a broad competition practice that is particularly focused on the tech and life sciences sectors. Her experience spans advising clients on strategic mandates around merger control, abuse of dominance, anticompetitive agreements and other compliance work. She also advises clients on emerging regulatory frameworks in the tech and life sciences areas.
Identified asa ‘notable practitioner’ by the legal directory Chambers and Partners, she is joining NRF fresh from being part of the Covington team that advised Brussels-based biopharmaceutical giant UCB on competition aspects of its $1.9bn acquisition of US outfit Zogenix, maker of potential ‘blockbuster’ epilepsy drug Fintepla, which completed last month.
Ian Giles, head of antitrust and competition at Norton Rose Fulbright for Europe, Middle and Asia, said: “Miranda has extremely impressive experience, particularly across technology and life sciences, and has worked with many of the top companies in these sectors.
This hire demonstrates our ongoing commitment to maintaining a top tier antitrust team, and building our Brussels capabilities at the heart of the EU in this time of significant regulatory change.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.